|
[1]
|
Li ZJ, Chen QL, Feng LZ, Rodewald L, Xia YY, Yu HL, et al. Active case finding with case management: the key to tackling the COVID-19 pandemic. Lancet 2020;396(10243):63 − 70. http://dx.doi.org/10.1016/S0140-6736(20)31278-2CrossRef
|
|
[2]
|
Chen HG, Zhang KL. Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China. Eur Respir J 2020;56(3):2002710. http://dx.doi.org/10.1183/13993003.02710-2020CrossRef
|
|
[3]
|
Huang F, Xia YY, Chen H, Wang N, Du X, Chen W, et al. The impact of the COVID-19 epidemic on tuberculosis control in China. Lancet Reg Health: West Pac 2020;3:100032. http://dx.doi.org/10.1016/j.lanwpc.2020.100032CrossRef
|
|
[4]
|
Wu Z, Chen J, Xia Z, Pan Q, Yuan Z, Zhang W, et al. Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China. Int J Tuberc Lung Dis 2020;24(10):1122 − 4. http://dx.doi.org/10.5588/ijtld.20.0539CrossRef
|
|
[5]
|
Liu Q, Lu P, Shen Y, Li CW, Wang JM, Zhu LM, et al. Collateral impact of the coronavirus disease 2019 (COVID-19) pandemic on tuberculosis control in Jiangsu province, China. Clin Infect Dis 2020ciaa1289. http://dx.doi.org/10.1093/cid/ciaa1289CrossRef
|
|
[6]
|
Pan A, Liu L, Wang CL, Guo H, Hao XJ, Wang Q, et al. Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA 2020;323(19):1915 − 23. http://dx.doi.org/10.1001/jama.2020.6130CrossRef
|
|
[7]
|
Tian HY, Liu YH, Li YD, Wu CH, Chen B, Kraemer MUG, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science 2020;368(6491):638 − 42. http://dx.doi.org/10.1126/science.abb6105CrossRef
|
|
[8]
|
Desta KT, Kessely DB, Daboi JG. Evaluation of the performance of the National Tuberculosis Program of Liberia during the 2014-2015 Ebola outbreak. BMC Public Health 2019;19(1):1221. http://dx.doi.org/10.1186/s12889-019-7574-7CrossRef
|